Baxter International, Inc. (BAX)
26.13
+0.20
(+0.77%)
USD |
NYSE |
Aug 28, 16:00
26.12
-0.01
(-0.04%)
Pre-Market: 20:00
Baxter International Free Cash Flow : 812.00M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 812.00M |
| March 31, 2026 | 714.00M |
| December 31, 2025 | 323.00M |
| September 30, 2025 | 235.00M |
| June 30, 2025 | 340.00M |
| March 31, 2025 | 313.00M |
| December 31, 2024 | 681.00M |
| September 30, 2024 | 764.00M |
| June 30, 2024 | 886.00M |
| March 31, 2024 | 1.033B |
| December 31, 2023 | 1.294B |
| September 30, 2023 | 1.112B |
| June 30, 2023 | 888.00M |
| March 31, 2023 | 837.00M |
| December 31, 2022 | 591.00M |
| September 30, 2022 | 792.00M |
| June 30, 2022 | 1.159B |
| March 31, 2022 | 1.341B |
| December 31, 2021 | 1.479B |
| September 30, 2021 | 1.496B |
| June 30, 2021 | 1.354B |
| March 31, 2021 | 1.265B |
| December 31, 2020 | 1.159B |
| September 30, 2020 | 1.322B |
| June 30, 2020 | 1.502B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.573B |
| December 31, 2019 | 1.408B |
| September 30, 2019 | 1.273B |
| June 30, 2019 | 1.053B |
| March 31, 2019 | 1.001B |
| December 31, 2018 | 1.358B |
| September 30, 2018 | 1.145B |
| June 30, 2018 | 1.305B |
| March 31, 2018 | 1.429B |
| December 31, 2017 | 1.203B |
| September 30, 2017 | 1.426B |
| June 30, 2017 | 1.284B |
| March 31, 2017 | 1.518B |
| December 31, 2016 | 935.00M |
| September 30, 2016 | 893.00M |
| June 30, 2016 | 582.00M |
| March 31, 2016 | 461.00M |
| December 31, 2015 | 860.00M |
| September 30, 2015 | 1.231B |
| June 30, 2015 | 2.344B |
| March 31, 2015 | 2.034B |
| December 31, 2014 | 2.29B |
| September 30, 2014 | 2.043B |
| June 30, 2014 | 1.477B |
| March 31, 2014 | 1.717B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Becton, Dickinson & Co. | 2.533B |
| DexCom, Inc. | 1.405B |
| Boston Scientific Corp. | 3.625B |
| West Pharmaceutical Services, Inc. | 436.90M |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 285.00M |
| Cash from Investing (Quarterly) | -117.00M |
| Cash from Financing (Quarterly) | -31.00M |
| Free Cash Flow Per Share (Quarterly) | 0.3205 |
| Free Cash Flow to Equity (Quarterly) | 996.00M |
| Free Cash Flow to Firm (Quarterly) | 230.08M |
| Free Cash Flow Yield | 6.03% |